Redefining the standards of pharmaceutical intermediates through chemical excellence.
As a cornerstone in the production of xanthine derivatives and various API formulations, 1,3-dimethyl-6-aminouracil holds a pivotal industry status. Our production process utilizes state-of-the-art catalytic hydrogenation and precise temperature control to ensure a molecular structure that maximizes reactivity and purity, meeting the stringent requirements of the global pharmaceutical supply chain.
The technical superiority of our product lies in its ultra-low impurity profile and exceptional crystallization stability. By implementing a multi-stage purification sequence, we eliminate trace organic volatile compounds, providing a consistent crystalline form that facilitates seamless integration into downstream synthesis, thereby reducing overall production costs and increasing final drug efficacy.
Three core pillars ensuring the absolute reliability of our pharmaceutical intermediates.
Advanced separation techniques ensuring the highest grade of chemical consistency.
Seamless transition from lab-scale samples to industrial volume production.
Rigorous stability testing to ensure product longevity during shipping.
Quantitative verification of our production excellence.
Detailed chemical parameters for 1,3-dimethyl-6-aminouracil.
Empowering pharmaceutical breakthroughs across diverse global applications.
Integrated our high-purity intermediate to reduce byproduct formation in xanthine production.
Successfully scaled production of a novel diuretic drug using our intermediate as a primary building block.
Our rigorous purity documentation helped a partner accelerate their FDA filing process.
Used our base material to create high-affinity ligands for protein binding studies.
Switched to our streamlined supply chain, reducing raw material overhead by 15%.
Improved the shelf-life of their finished product by using our moisture-controlled crystals.
Tailored solutions for demanding pharmaceutical environments.
Serving as the primary precursor for caffeine, theophylline, and theobromine analogues.
Essential for the structural framework of advanced diuretic agents in cardiovascular medicine.
Utilized in enzymatic assays and cellular signaling studies as a high-purity reagent.
Providing a stable core for the development of proprietary active pharmaceutical ingredients.
Used as a reference standard for studying uracil metabolism in clinical chemistry.
Application in biocompatible polymer coatings for controlled drug release systems.
Our entire production chain follows strict ISO quality management systems, ensuring that every drum of intermediate is traceable from raw material to final shipment.
Manufacturing occurs in GMP-certified facilities with controlled atmospheric conditions to prevent cross-contamination and degradation.
Every batch is accompanied by a detailed Certificate of Analysis (CoA), providing full transparency on purity, moisture, and impurity levels.
Our commitment to purity is verified by independent third-party laboratories globally.
Expert answers to common technical and commercial inquiries.
Secure a stable supply of high-purity 1,3-dimethyl-6-aminouracil with guaranteed compliance and global logistics support.